1. Academic Validation
  2. Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases

Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases

  • ACS Med Chem Lett. 2025 Jun 2;16(6):980-981. doi: 10.1021/acsmedchemlett.5c00305.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
Abstract

Provided herein are novel bicyclic heterocycles as MRGPRX2 antagonists, pharmaceutical compositions, use of such compounds in treating inflammatory diseases, and processes for preparing such compounds.

Figures
Products